Skip to content

Clinical trials

Phase 1 Hypersensitivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 1 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20052
20062
20072
20081
20093
20102
20111
20121
20135
20141
20151
20161
20181
20191
20202
20211
20221
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of North Carolina, Chapel Hill5
Andrew D. Luster, M.D.,Ph.D.2
National Institute of Allergy and Infectious Diseases (NIAID)2
ALK-Abelló A/S1
Alcon Research1
Allergy Therapeutics1
Allertein Therapeutics, LLC1
Alton Melton1
Aquestive Therapeutics1
Beth Israel Deaconess Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity31
Asthma12
Peanut Hypersensitivity4
Food Hypersensitivity3
Hypersensitivity, Immediate3
Rhinitis, Allergic3
Inflammation2
Rhinitis, Allergic, Perennial2
Angioedema1
Angioedemas, Hereditary1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.